Back to calendar
CytomX Therapeutics, Inc. (CTMX) Earnings
CTMX reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · After Market Close
Q2 2026
Est. EPS: $-0.07
Actual EPS: $-0.09
EPS surprise: -16.76%
Company overview
Market Cap$761.6M
PriceUSD 3.50
EPS (TTM)-0.46
52-week high8.21
52-week low1.72
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees69